The packaging region Ψ is the RNA sequence which directs the inclusion of genomic viral RNA into virions. As such it represents an apparently accessible site for ribozyme action. Ribozymes directed against the Ψ site of Moloney murine leukaemia virus (MoMLV) were delivered to target cells using a related retroviral vector, LNL6. LNL6 is a vector predominantly derived from MoMLV and, like all retroviruses, requires the Ψ region to be packaged. By exploiting the heterogeneity between nucleotide sequences of the MoMLV target and LNL6 vector in the Ψ packaging region, two ribozymes were designed and shown to selectively cleave the target but not the vector sequence. Clonally derived cell lines expressing ribozymes showed inhibition of virus replication. These results show the utility of catalytic RNA as specific antiviral agents.
The packaging region Ψ is the RNA sequence which directs the inclusion of genomic viral RNA into virions. As such it represents an apparently accessible site for ribozyme action. Ribozymes directed against the Ψ site of Moloney murine leukaemia virus (MoMLV) were delivered to target cells using a related retroviral vector, LNL6. LNL6 is a vector predominantly derived from MoMLV and, like all retroviruses, requires the Ψ region to be packaged. By exploiting the heterogeneity between nucleotide sequences of the MoMLV target and LNL6 vector in the Ψ packaging region, two ribozymes were designed and shown to selectively cleave the target but not the vector sequence. Clonally derived cell lines expressing ribozymes showed inhibition of virus replication. These results show the utility of catalytic RNA as specific antiviral agents.
Ribozymes are naturally occurring RNA molecules with a catalytic activity that can cleave RNA. The hammerhead ribozyme motif was proposed by O. C. Uhlenbeck, based on previous studies of self-cleaving satellite RNA of tobacco ring spot virus (Uhlenbeck, 1987) . Subsequently, hammerhead ribozymes have been engineered and shown to mediate the cleavage of specific target RNA molecules in vitro (Haseloff & Gerlach, 1988) . This was accomplished by flanking the catalytic core of the ribozyme with two complementary sequences thereby allowing base-pairing and subsequent target recognition between ribozyme construct RNA and substrate RNA (Perriman et al., 1992) . Such ribozyme constructs have been shown to mediate the down-regulation of viral gene expression in a variety of tissue culture systems (Tang et al., 1994 ; Zhao & Pick, 1993) , including the inhibition of bovine leukaemia virus (BLV) (Cantor et al., 1993) and human immunodeficiency virus type 1 (Ojwang et al., 1992) . Moloney Author for correspondence : Geoff Symonds.
Fax j61 2 360 9813. e-mail jjphar09!angis.su.oz.au murine leukaemia virus (MoMLV) is a retrovirus able to infect a range of murine cells and to induce viraemia and consequent lymphocytic neoplasms in BALB\c mice (Dunn et al., 1962) .
Replication-defective recombinant retroviral vectors have the ability to introduce exogenous genes into target cells (Miller, 1992) . This has proven to be useful for modification of cellular phenotype, including cell transformation, and for the ex vivo manipulation of cells for the purpose of gene therapy. In the present study, the LNL6 retroviral vector (Bender et al., 1987) was used to deliver, integrate and express anti-MoMLV ribozyme constructs in target cells. Since LNL6 is a MoMLVbased vector, ribozymes that would distinguish between MoMLV target and the LNL6 vector were required. The fulllength genomic sequences of MoMLV and LNL6 were compared and a region of heterogeneity was identified within the Ψ packaging sequence. This region is a cis-acting viral genomic sequence necessary for the specific packaging of viral RNA into viral particles and interacts with virion capsid protein (Bender et al., 1987) . Interruption of this interaction has been shown to block the retroviral replication cycle and deletion mutants in this region are not packaged into virions (Sullenger et al., 1990) . In previous studies (Han et al., 1991) , antisense RNA complementary to the packaging region has been shown to inhibit virus replication in cell lines, and transgenic mice expressing the same antisense RNA to this region showed a reduction in both viraemia and the induction of leukaemia (Han et al., 1991) .
In this report, we show that ribozymes designed to target the retroviral packaging region can distinguish between vector and target. Ribozymes specifically cleave MoMLV but not LNL6 Ψ sequence in an in vitro cleavage assay. When introduced into NIH3T3 cells by infection, these constructs inhibited replication of MoMLV.
Ribozymes designed to target the Ψ packaging region of the MoMLV genome were delivered to target cells using the MoMLV based retroviral vector LNL6. MoMLV and LNL6 use the same viral proteins for packaging and replication. For LNL6, these proteins are supplied in trans by the ΨCRE packaging cell line (Danos & Mulligan, 1988) . Targeting the RNA sequences encoding these proteins would not only have resulted in a reduction of MoMLV virus production in infected 0001-4775 # 1997 SGM Fig. 1 . In vitro cleavage of in vitro generated MoMLV packaging region and LNL6 RNA. Plasmid pGEMΨ contains the Bal I-Bal I fragment of the Ψ packaging sequence of MoMLV (Sun et al., 1994) . A BstEII-ScaIII fragment of pLNL6 was cloned into pGEM-3Zf(j) to create pGEMLNL6. These two plasmids were used to generate transcripts for in vitro cleavage reactions. Complementary oligonucleotides encoding ribozymes Rz11 and Rz12 were annealed, phosphorylated and then cloned into the Sal Idigested and dephosphorylated site of the transcription plasmid pT3T7. pGEM366 (Sun et al., 1994) contained a ribozyme designed to target an adjacent sequence present in both the MoMLV target and the LNL6 vector. Run-off transcription reactions were performed using an RNA transcription kit. Both substrate and target were radiolabelled with [α-32 P]UTP. For cleavage reactions, the ribozymes and substrate (molar ratio 1 : 1) were pre-incubated at 80 mC in the absence of MgCl 2 , followed by 30 min incubation at 50 mC in the presence of 50 mM Tris-HCl (pH 7n5) and 10 mM MgCl 2 . Fragments were separated by electrophoresis on 6 % acrylamide. Ribozymes Rz11 and Rz12 were incubated with either MoMLV or LNL6 target sequence. cells but would also be expected to cause a reduction in viral titre for LNL6 within the original packaging cell line. This was undesirable since high viral titre is required to infect target cells. The ribozymes were therefore designed to target a structural portion of the viral RNA genome in which there were sequence differences between MoMLV and LNL6. The 5h portion of LNL6, including the long terminal repeat (LTR) and part of the Ψ packaging region is derived from Moloney murine sarcoma virus (MoMSV) rather than MoMLV (Bender et al., 1987) . The resulting hybrid LNL6 genome varies slightly in the packaging region site when compared with MoMLV. This sequence diversity was exploited and two ribozymes (Rz11 and Rz12) were engineered with specificity to cleave MoMLV but leave LNL6 intact.
An in vitro cleavage assay was used to confirm that the engineered ribozymes could differentiate between MoMLV target and LNL6 vector sequences. In these experiments, it was confirmed that the ribozymes Rz11 and Rz12 cleaved the MoMLV target, yielding fragments of the expected size, but did not cleave the analogous vector pLNL6 sequence (lanes 3-6, Fig. 1 ). The additional ribozyme construct Rz366 (Sun et al., 1994) , targeted to an adjacent sequence appearing in both the MoMLV target and the LNL6 vector, was shown to cleave both LNL6 and MoMLV (lanes 7-10, Fig. 1) . Therefore it was shown that ribozymes Rz11 and Rz12 were indeed able to effectively cleave MoMLV, generating the correct size cleavage fragments, whereas LNL6 as expected, was resistant to cleavage. In these test-tube reactions, ribozymes and their target substrates diffuse freely, and the cleavage reaction can occur as rapidly as RNA duplex formation (Cech et al., 1992) . In cells, RNA molecules do not appear to diffuse freely but are sorted to specific cellular locations. Such compartmentalization of viral RNAs may therefore reduce their accessibility to ribozymes (Sullenger & Cech, 1993) .
The replication kinetics of MoMLV were determined by titrating virus on NIH3T3 cells. This titration was performed in order to be able to discern in an assay whether inhibition of virus replication was occurring. It was established that NIH3T3 cells would reach confluence in 6 days when initially seeded at 10% cells per well in six-well plates. To determine the optimal initial infection dose of MoMLV, serial dilutions ranging from 10 −" to 10 −$ dilutions of MoMLV-containing supernatant were prepared and used to infect 10% NIH3T3 cells plated 24 h previously. Virus-containing supernatant was harvested every 24 h for four consecutive days, by collecting the supernatant and completely replacing the medium. A 10 −$ dilution of the stored MoMLV was found to be the optimal infection dose. At this initial dose, virus production plateaued at day 4 and could be clearly visualized by dot blot analysis (data not shown). Virus production plateaued earlier than day 4 when the initial dose used was higher than the 10 −$ dilution. In no instance did the infected cells show cytopathic effects.
Recombinant retrovirus for each different ribozyme and ribozyme control construct was produced and titred (Danos & Mulligan, 1988) ; all producer lines were demonstrated to be free of RCR (Danos & Mulligan, 1988) . NIH3T3 cells were infected with recombinant retroviruses expressing the various constructs. Five clonal cell lines (1-5) for each of the constructs, Rz11, Rz12 and LNL6 were established. These clones were put under G418 selection, and then challenged with previously titrated MoMLV virus. Four days post-challenge supernatants were collected and a viral dot blot assay performed using a gagspecific primer. A reduction was found in MoMLV replication Fig. 2. (a) Challenge with MoMLV of clonal populations of ribozyme-expressing NIH3T3 cells. Virus-containing medium (1 ml) was harvested from cell cultures and centrifuged at 500 g for 5 min following challenge with MoMLV. Supernatant was collected on day 4 post-challenge ; 0n9 ml was then transferred to a fresh tube and the viral RNA precipitated in 8 % polyethelene glycol (PEG) 8000 and 0n5 M NaCl, for 1 h at 4 mC followed by centrifugation at 12 000 g for 10 min. After phenol-chloroform-isoamyl alcohol (25 : 24 : 1) extraction, RNA was blotted onto positively charged nylon membranes in an alkaline transfer solution according to manufacturer's protocol, and then hybridized with a gag probe in ExpressHyb solution. this probe was created by PCR, amplifying a 500 bp fragment of the gag gene by using primers 5h GTAAAAGGAATAACACAAGGGC and 3h TTTCTTGGGACAATCTTTAGCC. Groups 1-5, duplicate samples of five randomly selected clones expressing Rz11, Rz12 and LNL6 control. (b) Graph showing results from (a) in phosphorimager pixel units.
Table 1. Inhibition of replication of MoMLV
Inhibition is given in parentheses as a percentage of the LNL6 vector control. for all of the ribozyme transduced clonal lines (Fig. 2 a, b) . The mean valuespthe standard error in phosphorimager units for five clones (in duplicate) of each construct are Rz11 34 822p18 157, Rz12 38 112p14 181 and LNL6 292 894p165 116. Additional experiments were performed to verify this inhibition of MoMLV replication. Two of the 5 Rz12 clones, numbers 2 and 3 were selected, as well as two of five Rz12m clones that had been selected in the same way. The Rz12m clones picked were 1 and 4. Both Rz12 and Rz12m clonal lines were challenged with the 10 −$ dilution of MoMLV and day 4 supernatants were assessed by performing dot blots and by reverse transcriptase assays (Goff et al., 1981) . The data in Table 1 represent the mean value of duplicate, independently processed samples, with the background levels subtracted shown. As shown, the dot blot experiments were repeated twice and the reverse transcriptase assays carried out once. Each of these experiments was performed independently and on different supernatants. In general, the pattern and level of inhibition was consistent with ribozyme-containing clones showing greater virus inhibition than those clones containing mutated ribozymes with the same antisense arms. Since these ribozymes are not catalytically active this result indicates an antisense effect. Even though the antisense molecules used are relatively short, the presence of the catalytic core, a structure conserved through evolution (Haseloff & Gerlach, 1988) , may result in a more stable and effective antisense molecule. This result is also consistent with the published observation of an antisense effect for a longer 540 base antisense sequence to the corresponding MoMLV Ψ region in transgenic mice (Han et al., 1991) .
Southern blots were performed on extracted genomic DNA. Different integration sites were identified for each construct (data not shown). Northern blot analysis showed the expression of the ribozyme constructs in NIH3T3 cells (data not shown).
It has been postulated that certain mRNAs carry destination signals to direct them to specific regions of the cytoplasm. Indeed, it has been shown that during oogenesis and early embryogenesis, maternal transcripts are localized via specific sequences to discrete areas within the cell (Ojwang et al., 1992) . Therefore the interaction between genomic viral RNA and their viral proteins in the cell cytoplasm is probably not a random occurrence. Rather, destination determinants in the genomic RNA and the viral mRNA or protein direct the components of mature virions to become co-localized in the host cell cytoplasm. B. A. Sullenger and colleagues previously reported that tethering the retroviral packaging signal to a ribozyme increased its ability to cleave (Sullenger & Cech, 1993) . Localization to the same cellular compartment is expected since both target and ribozymes contain the same MoMLV localization signal. Virions were analysed to examine whether the LNL6-ribozyme constructs were packaged into virions. Supernatant was collected from post-challenge virioncontaining supernatants. Virions in this supernatant were expected to contain viral genomes of MoMLV as well as LNL6-derived genomes encoding ribozymes. PCR primers were designed to amplify both MoMLV and LNL6. The region of LNL6 amplified is 19 bp shorter than the MoMLV fragment. The PCR reaction reveals the presence of both MoMLV and LNL6 in the post-challenge virus-containing supernatant, indicating that they are both expressed and have the potential to interact with one another (data not shown). Thus in this system localization of the two molecules to the same cellular compartment probably does occur.
In conclusion, we have established a system in which ribozymes targeted to the Ψ packaging region leave the retroviral vector intact while specifically cleaving their MoMLV target. By this means, replication of MoMLV can be inhibited by retrovirally introducing ribozyme constructs. These results indicate the utility and specificity of ribozymes targeted to the Ψ packaging region of MoMLV for the inhibition of virus replication.
